Maitland-Van der Zee, Anke-Hilse: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Pharmacogenetics of Phase II Drug Metabolizing Enzymes

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 787 KB

english, 2012

2

Methodological and statistical issues in pharmacogenomics

Bas J. M. Peters, Andrei S. Rodin, Anthonius De Boer, Anke-Hilse Maitland-van der Zee

Journal:

Journal of Pharmacy and Pharmacology

Year:

2010

Language:

english

File:

PDF, 207 KB

english, 2010

3

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Pharmacogenetics of Asthma and COPD

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 139 KB

english, 2012

4

Variants of ADAMTS1 modify the effectiveness of statins in reducing the risk of myocardial infarction

Peters, Bas J.M., Rodin, Andrei S., Klungel, Olaf H., Stricker, Bruno H.Ch., de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse

Journal:

Pharmacogenetics and Genomics

Year:

2010

File:

PDF, 164 KB

2010

5

Bronchiectasis in Severe Asthma: Does It Make a Difference?

Bendien, Sarah Alice, van Loon-Kooij, Stephanie, Kramer, Gerdien, Huijgen, Willemijn, Altenburg, Josje, Ten Brinke, Anneke, Maitland-van der Zee, Anke-Hilse

Journal:

Year:

2020

File:

PDF, 268 KB

2020

6

The effectiveness of HMG-CoA reductase inhibitors in an elderly population is independent of apolipoprotein E-genotypes

Anke-Hilse Maitland-van der Zee, Bruno H. CH. Stricker, Olaf H. Klungel, John J. P. Kastelein, Albert Hofman, Hubertus G. M. Leufkens, Christine Van Broeckhoven, Cornelia M. Van Duijn, Anthonius De Bo

Journal:

British Journal of Clinical Pharmacology

Year:

2002

Language:

english

File:

PDF, 178 KB

english, 2002

7

Reasons for non-response in observational pharmacogenetic research

Diane B.M.A. van Wieren-de Wijer, Anke-Hilse Maitland-van der Zee, Anthonius de Boer, Abraham A. Kroon, Peter W. de Leeuw, Paul Schiffers, Rob G.J.H. Janssen, Bruce M. Psaty, Cornelia M. van Duijn, Br

Journal:

Pharmacoepidemiology and Drug Safety

Year:

2009

Language:

english

File:

PDF, 91 KB

english, 2009

8

Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study

Ellen S. Koster, Jan A. M. Raaijmakers, Susanne J. H. Vijverberg, Anke-Hilse Maitland-van der Zee

Journal:

Pharmacoepidemiology and Drug Safety

Year:

2011

Language:

english

File:

PDF, 164 KB

english, 2011

9

Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment

Diane B. M. A. van Wieren-de Wijer, Anke-Hilse Maitland-van der Zee, Anthonius de Boer, Bruno H. Ch. Stricker, Abraham A. Kroon, Peter W. de Leeuw, O. Bozkurt, Olaf H. Klungel

Journal:

International Journal of Clinical Pharmacy

Year:

2009

Language:

english

File:

PDF, 174 KB

english, 2009

10

From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics

Bob Wilffert, Jesse Swen, Hans Mulder, Daan Touw, Anke-Hilse Maitland-Van der Zee, Vera Deneer, KNMP working group Pharmacogenetics

Journal:

International Journal of Clinical Pharmacy

Year:

2011

Language:

english

File:

PDF, 178 KB

english, 2011

11

Systematic Review of Pharmacogenetic Warfarin Dosing

Rianne M. F. van Schie, Andrea L. Jorgensen, Anthonius de Boer, Anke-Hilse Maitland-van der Zee, for the EU-PACT study group

Journal:

Journal of General Internal Medicine

Year:

2009

Language:

english

File:

PDF, 52 KB

english, 2009

12

Pharmacogenetics of response to statins: Where do we stand?

Anke-Hilse Maitland-van der Zee, Eric Boerwinkle

Journal:

Current Atherosclerosis Reports

Year:

2005

Language:

english

File:

PDF, 140 KB

english, 2005

13

Limited agreement between current and long-term asthma control in children: the PACMAN cohort study

Ellen S. Koster, Jan A. M. Raaijmakers, Susanne J. H. Vijverberg, Leo Koenderman, Dirkje S. Postma, Gerard H. Koppelman, Cornelis K. van der Ent, Anke-Hilse Maitland-van der Zee

Journal:

Pediatric Allergy and Immunology

Year:

2011

Language:

english

File:

PDF, 308 KB

english, 2011

14

Pharmacogenetics in health-care practice

Anke-Hilse Maitland-van der Zee, Olaf H. Klungel, Anthonius de Boer

Journal:

International Journal of Clinical Pharmacy

Year:

2004

Language:

english

File:

PDF, 47 KB

english, 2004

15

A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives

Verhoef, Talitha I, Redekop, William K, Darba, Josep, Geitona, Mary, Hughes, Dyfrig A, Siebert, Uwe, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse, Barallon, Rita, Briz, Montserrat

Journal:

Pharmacogenomics

Year:

2010

Language:

english

File:

PDF, 1.44 MB

english, 2010

16

AAPS–FIP Summary Workshop Report: Pharmacogenetics in Individualized Medicine: Methods, Regulatory, and Clinical Applications

Majid Moridani, Anke-Hilse Maitland-van der Zee, Hitoshi Sasaki, Ross McKinnon, Lawrence Fleckenstein, Vinod P. Shah

Journal:

The AAPS Journal

Year:

2009

Language:

english

File:

PDF, 73 KB

english, 2009

17

Exhaled NO is a poor marker of asthma control in children with a reported use of asthma medication: a pharmacy-based study

Susanne J. H. Vijverberg, Ellen S. Koster, Leo Koenderman, Hubertus G. M. Arets, Cornelis K. van der Ent, Dirkje S. Postma, Gerard H. Koppelman, Jan A. M. Raaijmakers, Anke-Hilse Maitland-van der Zee

Journal:

Pediatric Allergy and Immunology

Year:

2012

Language:

english

File:

PDF, 191 KB

english, 2012

18

Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: The Genetics of Hypertension-Associated Treatment (GenHAT) study

Anke-Hilse Maitland-van der Zee, Eric Boerwinkle, Donna K. Arnett, Barry R. Davis, Catherine Leiendecker-Foster, Michael B. Miller, Olaf H. Klungel, Charles E. Ford, John H. Eckfeldt

Journal:

American Heart Journal

Year:

2007

Language:

english

File:

PDF, 91 KB

english, 2007

19

Demographic, Environmental, and Genetic Predictors of Metabolic Side Effects of Hydrochlorothiazide Treatment in Hypertensive Subjects

Anke-Hilse Maitland-van der Zee, Stephen T. Turner, Gary L. Schwartz, Arlene B. Chapman, Olaf H. Klungel, Eric Boerwinkle

Journal:

American Journal of Hypertension

Year:

2005

Language:

english

File:

PDF, 151 KB

english, 2005

20

Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes

Rebecca Howard, Julian B.S. Leathart, David J. French, Elaina Krishan, Hugo Kohnke, Mia Wadelius, Rianne van Schie, Talitha Verhoef, Anke-Hilse Maitland-van der Zee, Ann K. Daly, Rita Barallon

Journal:

Clinica Chimica Acta

Year:

2011

Language:

english

File:

PDF, 963 KB

english, 2011

21

Genetic determinants of response to statins

Peters, Bas JM, Klungel, Olaf H, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse

Journal:

Expert Review of Cardiovascular Therapy

Year:

2009

Language:

english

File:

PDF, 229 KB

english, 2009

22

Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism

Anke-Hilse Maitland-van der Zee, Bruno H.Ch Stricker, Olaf H Klungel, John J.P Kastelein, Albert Hofman, Jacqueline C.M Witteman, Hubertus G.M Leufkens, Cornelia M.van Duijn, Anthonius de Boer

Journal:

Atherosclerosis

Year:

2004

Language:

english

File:

PDF, 43 KB

english, 2004

23

Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI

Bas J.M. Peters, Helmi Pett, Olaf H. Klungel, Bruno H. Ch. Stricker, Bruce M. Psaty, Nicole L. Glazer, Kerri L. Wiggins, Josh C. Bis, Anthonius de Boer, Anke-Hilse Maitland-van der Zee

Journal:

Atherosclerosis

Year:

2011

Language:

english

File:

PDF, 289 KB

english, 2011

24

Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors

Anke-Hilse Maitland-van der Zee, Olaf H. Klungel, Bruno H.Ch. Stricker, W.M. Monique Verschuren, John J.P. Kastelein, Hubertus G.M. Leufkens, Anthonius de Boer

Journal:

Atherosclerosis

Year:

2002

Language:

english

File:

PDF, 133 KB

english, 2002

25

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Supplemental Images

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 206 KB

english, 2012

26

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Pharmacogenetics: A Historical Perspective

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 89 KB

english, 2012

27

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Pharmacogenetics in Drug Metabolism: Role of Phase I Enzymes

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 378 KB

english, 2012

28

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Frontmatter

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 70 KB

english, 2012

29

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Pharmacogenetics of Drug Transporters

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 268 KB

english, 2012

30

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Pharmacogenetics in Cancer

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 137 KB

english, 2012

31

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Cardiovascular Pharmacogenetics

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 186 KB

english, 2012

32

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Pharmacogenetics of Drug Targets

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 444 KB

english, 2012

33

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Pharmacogenomics of Inflammatory Bowel Diseases

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 231 KB

english, 2012

34

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Role of Pharmacogenetics in Registration Processes

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 181 KB

english, 2012

35

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Pharmacogenetics of Adverse Drug Reactions

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 370 KB

english, 2012

36

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Pharmacogenetics in Psychiatry

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 217 KB

english, 2012

37

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Pharmacogenetics of Pain Medication

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 349 KB

english, 2012

38

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Ethical and Social Issues in Pharmacogenomics Testing

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 160 KB

english, 2012

39

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Applications of Pharmacogenetics in Pharmaceutical Research and Development

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 168 KB

english, 2012

40

Pharmacogenetics and Individualized Therapy (Maitland-van der Zee/Pharmacogenetics) || Developments in Analyses in Pharmacogenetic Datasets

Maitland-van der Zee, Anke-Hilse, Daly, Ann K.

Year:

2012

Language:

english

File:

PDF, 123 KB

english, 2012

41

Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon

Verhoef, Talitha I., Redekop, William K., Daly, Ann K., van Schie, Rianne M. F., de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse

Journal:

British Journal of Clinical Pharmacology

Year:

2014

Language:

english

File:

PDF, 638 KB

english, 2014

42

Statin Prescribing in the Elderly in the Netherlands

Drs Marjolein Geleedst-De Vooght, Anke-Hilse Maitland-van der Zee…

Journal:

Year:

2010

Language:

english

File:

PDF, 138 KB

english, 2010

43

The Degree of Personal Communicability of Pulmonary Tuberculosis.

Maitland-van der Zee, Anke-Hilse

Journal:

Year:

1908

Language:

english

File:

PDF, 326 KB

english, 1908

44

Pharmacogenetics of statins

Maitland-van der Zee, Anke-Hilse

Journal:

Clinical Biochemistry

Year:

2013

Language:

english

File:

PDF, 121 KB

english, 2013

45

Pharmacogenetics and pharmacogenomics: practical applications in routine medical practice

Anke-Hilse Maitland-van der Zee,Ana Alfirevic

Journal:

Genome Medicine

Year:

2010

Language:

english

File:

PDF, 253 KB

english, 2010

46

Beliefs about medicines in Dutch acenocoumarol and phenprocoumon users

Verhoef, Talitha I., Redekop, W. Ken, Bouvy, Marcel L., Dorenbos, Brenda, Karwar, Zamiera, van Schie, Rianne M. F., de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse

Journal:

British Journal of Clinical Pharmacology

Year:

2014

Language:

english

File:

PDF, 883 KB

english, 2014

47

Clinical and economic consequences of pharmacogenetic-guided dosing of warfarin

Verhoef, Talitha I, Schalekamp, Tom, Redekop, William K, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse

Journal:

Expert Review of Pharmacoeconomics & Outcomes Research

Year:

2010

Language:

english

File:

PDF, 197 KB

english, 2010

48

Genotype-guided coumarin dosing: where are we now and where do we need to go next?

Baranova, Ekaterina V, Verhoef, Talitha I, Asselbergs, Folkert W, de Boer, Anthonius, Maitland-van der Zee, Anke-Hilse

Journal:

Expert Opinion on Drug Metabolism & Toxicology

Year:

2015

Language:

english

File:

PDF, 403 KB

english, 2015

49

Astmadiagnose bij kinderen

Pieters, Lydia, Vijverberg, Susanne, Raaijmakers, Jan, van der Ent, Kors, Maitland-van der Zee, Anke-Hilse

Journal:

Huisarts en wetenschap

Year:

2014

Language:

dutch

File:

PDF, 783 KB

dutch, 2014

50

The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study

de Keyser, Catherine E., Peters, Bas J.M., Becker, Matthijs L., Visser, Loes E., Uitterlinden, André G., Klungel, Olaf H., Verstuyft, Céline, Hofman, Albert, Maitland-van der Zee, Anke-Hilse, Stricker

Journal:

Pharmacogenetics and Genomics

Year:

2014

Language:

english

File:

PDF, 447 KB

english, 2014

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски